Atkins MB - Search Results

1

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA; National Comprehensive Cancer Network. Brahmer JR, et al. Among authors: atkins mb. J Clin Oncol. 2018 Jun 10;36(17):1714-1768. doi: 10.1200/JCO.2017.77.6385. Epub 2018 Feb 14. J Clin Oncol. 2018. PMID: 29442540 Free PMC article.

2

Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy.

Atkins MB, Vachino G, Tilg HJ, Karp DD, Robert NJ, Kappler K, Mier JW. Atkins MB, et al. J Clin Oncol. 1992 Nov;10(11):1802-9. doi: 10.1200/JCO.1992.10.11.1802. J Clin Oncol. 1992. PMID: 1403061 Clinical Trial.

3

Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma.

Atkins MB, O'Boyle KR, Sosman JA, Weiss GR, Margolin KA, Ernest ML, Kappler K, Mier JW, Sparano JA, Fisher RI, et al. Atkins MB, et al. J Clin Oncol. 1994 Aug;12(8):1553-60. doi: 10.1200/JCO.1994.12.8.1553. J Clin Oncol. 1994. PMID: 8040667 Clinical Trial.

4

Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma.

Sparano JA, Fisher RI, Sunderland M, Margolin K, Ernest ML, Sznol M, Atkins MB, Dutcher JP, Micetich KC, Weiss GR, et al. Sparano JA, et al. Among authors: atkins mb. J Clin Oncol. 1993 Oct;11(10):1969-77. doi: 10.1200/JCO.1993.11.10.1969. J Clin Oncol. 1993. PMID: 8410122 Clinical Trial.

5

Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma.

Fallick ML, McDermott DF, LaRock D, Long JP, Atkins MB. Fallick ML, et al. Among authors: atkins mb. J Urol. 1997 Nov;158(5):1691-5. doi: 10.1016/s0022-5347(01)64097-7. J Urol. 1997. PMID: 9334580 Clinical Trial.

6

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.

Atkins MB, Lotze MT, Dutcher JP, Fisher RI, Weiss G, Margolin K, Abrams J, Sznol M, Parkinson D, Hawkins M, Paradise C, Kunkel L, Rosenberg SA. Atkins MB, et al. J Clin Oncol. 1999 Jul;17(7):2105-16. doi: 10.1200/JCO.1999.17.7.2105. J Clin Oncol. 1999. PMID: 10561265 Review.

7

Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.

Gollob JA, Mier JW, Veenstra K, McDermott DF, Clancy D, Clancy M, Atkins MB. Gollob JA, et al. Among authors: atkins mb. Clin Cancer Res. 2000 May;6(5):1678-92. Clin Cancer Res. 2000. PMID: 10815886 Clinical Trial.

8

A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanoma.

McDermott DF, Mier JW, Lawrence DP, van den Brink MR, Clancy MA, Rubin KM, Atkins MB. McDermott DF, et al. Among authors: atkins mb. Clin Cancer Res. 2000 Jun;6(6):2201-8. Clin Cancer Res. 2000. PMID: 10873069 Clinical Trial.

9

A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma.

Atkins MB, Redman B, Mier J, Gollob J, Weber J, Sosman J, MacPherson BL, Plasse T. Atkins MB, et al. Clin Cancer Res. 2001 Mar;7(3):486-92. Clin Cancer Res. 2001. PMID: 11297238 Clinical Trial.

10

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A. Balch CM, et al. Among authors: atkins mb. J Clin Oncol. 2001 Aug 15;19(16):3622-34. doi: 10.1200/JCO.2001.19.16.3622. J Clin Oncol. 2001. PMID: 11504744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

467 results

Search Page